Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (241) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (28) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (22) Apply Team member filter
- Videos (16) Apply Videos filter
- Financial reports (13) Apply Financial reports filter
- Webcasts and audio (13) Apply Webcasts and audio filter
- Analyst (12) Apply Analyst filter
- Event (7) Apply Event filter
- Investor contact (5) Apply Investor contact filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Oxford BioMedica notes the sBLA submission to FDA for Kymriah™ in adult patients with r/r DLBCL
Oxford, UK – 31 October 2017: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy
Oxford BioMedica notes the CTL019 MAA submission to the EMA for children, young adults with r/r B-cell ALL and adult patients with r/r DLBCL
Oxford, UK – 06 November 2017: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, today not
Responsible business
Oxford Biomedica is committed to its role as a responsible business and the Group has developed a policy and strategy to ensure it meets this objec
Kymriah (tisagenlecleucel, formerly CTL019) receives positive CHMP opinion for the treatment of two aggressive blood cancers, marking important milestone for patients in Europe
London, UK - 29 June 2018: Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell
LentiVector platform
The LentiVector® platform is the only commercially approved lentiviral-based gene delivery system.
The TRiP System
The TRiP SystemTM maximises viral vector production output and standardises downstream process
Packaging and producer cell lines
Oxford BioMedica has developed packaging and inducible producer cell lines that enable a simplified and scalable manufacturing process whil